Racial differences in idiopathic intracranial hypertension
- PMID: 18332344
- PMCID: PMC3010205
- DOI: 10.1212/01.wnl.0000304746.92913.dc
Racial differences in idiopathic intracranial hypertension
Abstract
Objective: To evaluate racial differences in idiopathic intracranial hypertension (IIH).
Methods: Medical records of all consecutive patients with definite IIH seen between 1989 and 2006 were reviewed. Demographics, associated factors, and visual function at presentation and follow-up were collected. Black patients were compared to non-black patients.
Results: We included 450 patients (197 black, 253 non-black). Obesity, systemic hypertension, anemia, and sleep apnea were more common in black patients than in non-black patients (p </= 0.01). CSF opening pressure was higher in black patients (40 vs 34 cm CSF, p < 0.001). Visual acuity, visual field loss, and degree of papilledema at presentation and follow-up were worse in black patients (p </= 0.01). Diagnostic and therapeutic measures were similar between black patients and non-black patients, except for optic nerve sheath fenestration (p = 0.01) and lumbar puncture (p = 0.03), both more commonly performed on black patients. The relative risk of severe visual loss for black patients compared with non-black patients was 3.5 (95% CI 2.0 to 5.8, p < 0.001) in at least one eye and 4.8 (95% CI 2.1 to 10.9, p < 0.001) in both eyes. Logistic regression analysis supported race, anemia, body mass index, and male gender as independent risk factors for severe visual loss and suggested that racial differences may be partially accounted for by differences in CSF opening pressure, body mass index, and frequency of anemia.
Conclusion: Black patients with idiopathic intracranial hypertension (IIH) were more likely than non-black patients with IIH to have severe visual loss in at least one eye. This difference did not appear to result from diagnosis, treatment, or access to care, but may partially relate to differences in other risk factors. Black patients have a more aggressive disease and may need closer follow-up and lower thresholds for early intervention.
Similar articles
-
Idiopathic intracranial hypertension in men.Neurology. 2009 Jan 27;72(4):304-9. doi: 10.1212/01.wnl.0000333254.84120.f5. Epub 2008 Oct 15. Neurology. 2009. PMID: 18923135 Free PMC article.
-
Differing presenting features of idiopathic intracranial hypertension in the UK and US.Eye (Lond). 2019 Jun;33(6):1014-1019. doi: 10.1038/s41433-019-0359-5. Epub 2019 Feb 19. Eye (Lond). 2019. PMID: 30783258 Free PMC article.
-
Idiopathic intracranial hypertension: a comparison between French and North-American white patients.Rev Neurol (Paris). 2009 Jun-Jul;165(6-7):542-8. doi: 10.1016/j.neurol.2008.11.021. Epub 2009 Jan 20. Rev Neurol (Paris). 2009. PMID: 19157473 Free PMC article.
-
Idiopathic Intracranial Hypertension - Challenges and Pearls.Neurol India. 2021 Nov-Dec;69(Supplement):S434-S442. doi: 10.4103/0028-3886.332276. Neurol India. 2021. PMID: 35103000 Review.
-
Fulminant Idiopathic Intracranial Hypertension.Curr Neurol Neurosci Rep. 2020 Mar 26;20(4):8. doi: 10.1007/s11910-020-1026-8. Curr Neurol Neurosci Rep. 2020. PMID: 32219578 Review.
Cited by
-
Association of MRI findings and visual outcome in idiopathic intracranial hypertension.AJR Am J Roentgenol. 2013 Aug;201(2):412-8. doi: 10.2214/AJR.12.9638. AJR Am J Roentgenol. 2013. PMID: 23883223 Free PMC article.
-
Factors associated with vision loss in idiopathic intracranial hypertension patients with severe papilledema.Eye (Lond). 2025 Jan;39(1):185-191. doi: 10.1038/s41433-024-03408-3. Epub 2024 Oct 30. Eye (Lond). 2025. PMID: 39478195
-
Evaluation of Racial, Ethnic, and Socioeconomic Disparities in Idiopathic Intracranial Hypertension.J Neuroophthalmol. 2025 Aug 6:10.1097/WNO.0000000000002388. doi: 10.1097/WNO.0000000000002388. Online ahead of print. J Neuroophthalmol. 2025. PMID: 40767867
-
Neuro-Ophthalmological Manifestations of Obstructive Sleep Apnea: Current Perspectives.Eye Brain. 2020 Jul 7;12:61-71. doi: 10.2147/EB.S247121. eCollection 2020. Eye Brain. 2020. PMID: 32753994 Free PMC article. Review.
-
Extent of transverse sinus stenosis does not predict visual outcomes in idiopathic intracranial hypertension.Eye (Lond). 2022 Jul;36(7):1390-1395. doi: 10.1038/s41433-021-01651-6. Epub 2021 Jun 28. Eye (Lond). 2022. PMID: 34183795 Free PMC article.
References
-
- Radhakrishnan K, Ahlskog JE, Cross SA, Kurland LT, O'Fallon WM. Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976 to 1990. Arch Neurol. 1993;50:78–80. - PubMed
-
- Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol. 1988;45:875–877. - PubMed
-
- Radhakrishnan K, Sridharan R, Ashok PP, Mousa ME. Pseudotumour cerebri: incidence and pattern in North-Eastern Libya. Eur Neurol. 1986;25:117–124. - PubMed
-
- Celebisoy N, Secil Y, Akyurekli O. Pseudotumor cerebri: etiological factors, presenting features and prognosis in the western part of Turkey. Acta Neurol Scand. 2002;106:367–370. - PubMed
-
- Mezaal M, Saadah M. Idiopathic intracranial hypertension in Dubai: nature and prognosis. Acta Neurol Scand. 2005;112:298–302. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources